BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38943731)

  • 21. The Level Short Chain Fatty Acids and HSP 70 in Colorectal Cancer and Non-Colorectal Cancer.
    Yusuf F; Adewiah S; Fatchiyah F
    Acta Inform Med; 2018 Oct; 26(3):160-163. PubMed ID: 30515005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary fatty acids and colorectal cancer risk in men: A report from the Shanghai Men's Health Study and a meta-analysis.
    Nguyen S; Li H; Yu D; Cai H; Gao J; Gao Y; Luu HN; Tran H; Xiang YB; Zheng W; Shu XO
    Int J Cancer; 2021 Jan; 148(1):77-89. PubMed ID: 32638381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Inflammatory and Immune Properties of Polyunsaturated Fatty Acids (PUFAs) and Their Impact on Colorectal Cancer (CRC) Prevention and Treatment.
    Tojjari A; Choucair K; Sadeghipour A; Saeed A; Saeed A
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
    Chang CC; Kao WY; Liu CY; Su HH; Kan YA; Lin PY; Ku WC; Chang KW; Yang RN; Huang CJ
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35417036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty acid composition of adipose tissue and colorectal cancer: a case-control study.
    Cottet V; Vaysse C; Scherrer ML; Ortega-Deballon P; Lakkis Z; Delhorme JB; Deguelte-Lardière S; Combe N; Bonithon-Kopp C
    Am J Clin Nutr; 2015 Jan; 101(1):192-201. PubMed ID: 25527763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells.
    Liu Z; Hopkins MM; Zhang Z; Quisenberry CB; Fix LC; Galvan BM; Meier KE
    J Pharmacol Exp Ther; 2015 Feb; 352(2):380-94. PubMed ID: 25491146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ω3 Polyunsaturated Fatty Acids as Immunomodulators in Colorectal Cancer: New Potential Role in Adjuvant Therapies.
    Miccadei S; Masella R; Mileo AM; Gessani S
    Front Immunol; 2016; 7():486. PubMed ID: 27895640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Anticancer Role of Omega-3 Polyunsaturated Fatty Acids was Closely Associated with the Increase in Genomic DNA Hydroxymethylation.
    Huang Q; Mo M; Zhong Y; Yang Q; Zhang J; Ye X; Zhang L; Cai C
    Anticancer Agents Med Chem; 2019; 19(3):330-336. PubMed ID: 30338745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway.
    Wei J; Zheng Z; Hou X; Jia F; Yuan Y; Yuan F; He F; Hu L; Zhao L
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116866. PubMed ID: 37429503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and Metabolical Pathways Associated with Microbiota-Derived Butyrate in Colorectal Cancer and Omega-3 Fatty Acids Implications: A Narrative Review.
    Gheorghe AS; Negru ȘM; Preda M; Mihăilă RI; Komporaly IA; Dumitrescu EA; Lungulescu CV; Kajanto LA; Georgescu B; Radu EA; Stănculeanu DL
    Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis.
    May-Wilson S; Sud A; Law PJ; Palin K; Tuupanen S; Gylfe A; Hänninen UA; Cajuso T; Tanskanen T; Kondelin J; Kaasinen E; Sarin AP; Eriksson JG; Rissanen H; Knekt P; Pukkala E; Jousilahti P; Salomaa V; Ripatti S; Palotie A; Renkonen-Sinisalo L; Lepistö A; Böhm J; Mecklin JP; Al-Tassan NA; Palles C; Farrington SM; Timofeeva MN; Meyer BF; Wakil SM; Campbell H; Smith CG; Idziaszczyk S; Maughan TS; Fisher D; Kerr R; Kerr D; Passarelli MN; Figueiredo JC; Buchanan DD; Win AK; Hopper JL; Jenkins MA; Lindor NM; Newcomb PA; Gallinger S; Conti D; Schumacher F; Casey G; Aaltonen LA; Cheadle JP; Tomlinson IP; Dunlop MG; Houlston RS
    Eur J Cancer; 2017 Oct; 84():228-238. PubMed ID: 28829991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-6 fatty acids can inhibit Fas-mediated apoptosis in a human colorectal carcinoma cell line: a potential mechanism for escape from immune surveillance.
    Meterissian S; Kontogiannea M; Murty H; Gupta A
    Int J Surg Investig; 2000; 2(4):253-7. PubMed ID: 12678526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel antidiabetic therapy: free fatty acid receptors as potential drug target.
    Sekiguchi H; Kasubuchi M; Hasegawa S; Pelisch N; Kimura I; Ichimura A
    Curr Diabetes Rev; 2015; 11(2):107-15. PubMed ID: 25732031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of dietary intake of specific polyunsaturated fatty acids (PUFAs) on colorectal cancer risk in Iran.
    Seyyedsalehi MS; Hadji M; Collatuzzo G; Rashidian H; Sasanfar B; Huybrechts I; Chajes V; Boffetta P; Zendehdel K
    Lipids; 2024 Mar; 59(2):41-53. PubMed ID: 38287648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer.
    Volpato M; Hull MA
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):545-555. PubMed ID: 29971573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyper-Elongation in Colorectal Cancer Tissue - Cerotic Acid is a Potential Novel Serum Metabolic Marker of Colorectal Malignancies.
    Mika A; Kobiela J; Czumaj A; Chmielewski M; Stepnowski P; Sledzinski T
    Cell Physiol Biochem; 2017; 41(2):722-730. PubMed ID: 28214830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.
    Zhang L; Zhou R; Zhang W; Yao X; Li W; Xu L; Sun X; Zhao L
    J Exp Clin Cancer Res; 2019 Mar; 38(1):120. PubMed ID: 30850009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in hepatic fatty acids reveal depletion of total polyunsaturated fatty acids following irinotecan plus 5-fluorouracil treatment in an animal model of colorectal cancer.
    Monirujjaman M; Pant A; Nelson R; Bathe O; Jacobs R; Mazurak VC
    Prostaglandins Leukot Essent Fatty Acids; 2021 Nov; 174():102359. PubMed ID: 34740033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.